RSS-Feed abonnieren

DOI: 10.1055/s-0045-1801886
Catch-22 Situation with Unexpected Reports in Acute Lymphoblastic Leukemia
Funding None.
Abstract
Central nervous system (CNS) infections are relatively common among children receiving treatment for acute lymphoblastic leukemia (ALL). However, diagnosing these infections presents challenges. In this report, we present a case of asymptomatic adenoviral meningitis, which presented a diagnostic challenge as it mimicked CNS involvement in a child undergoing treatment for ALL. Our findings underscore the importance of thorough diagnostic evaluation for CNS infections in children undergoing ALL therapy, whether they present with symptoms or exhibit asymptomatic cerebrospinal fluid pleocytosis. Furthermore, distinguishing between infections and CNS leukemia is critical, highlighting the necessity of employing flow cytometry to mitigate the potential misinterpretation of morphological features.
Patient Consent
Patient consent is not required in this study.
Author Contributions
S.P. wrote the manuscript, A.T. is the clinician involved in treatment and contributed to betterment of manuscript, P.G. is the Cytopathologist who reported the CSF samples and provided the required images.
Publikationsverlauf
Artikel online veröffentlicht:
04. Februar 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Das N, Banavali S, Bakhshi S. et al. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India. Trials 2022; 23 (01) 102
- 2 Blaney SM, Adamson PC, Helman LJ. Pizzo and Poplack's Pediatric Oncology. Vol. 1. 8th ed.. Philadelphia, PA: Wolters Kluwer; 2021
- 3 Winick N, Devidas M, Chen S. et al. Impact of initial CSF findings on outcome among patients with national cancer institute standard- and high-risk b-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. J Clin Oncol 2017; 35 (22) 2527-2534
- 4 Schultz KR, Pullen DJ, Sather HN. et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 2007; 109 (03) 926-935
- 5 Larsen EC, Salzer WL, Devidas M. et al. Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): a report from the Children's Oncology Group Study AALL0232. JCO 2011; 29 (18, suppl): 3
- 6 Jeha S, Pei D, Choi J. et al. Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16. J Clin Oncol 2019; 37 (35) 3377-3391
- 7 Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons. Leuk Lymphoma 2010; 51 (02) 261-268
- 8 Thastrup M, Marquart HV, Levinsen M. et al; Nordic Society of Pediatric Hematology and Oncology (NOPHO). Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study. Leukemia 2020; 34 (02) 336-346
- 9 Shieh WJ. Human adenovirus infections in pediatric population - An update on clinico-pathologic correlation. Biomed J 2022; 45 (01) 38-49